Search

Your search keyword '"Gram, Inger T."' showing total 16 results
Start Over Author "Gram, Inger T." Publisher springer science and business media llc
16 results on '"Gram, Inger T."'

2. Circulating inflammatory biomarkers, adipokines and breast cancer risk—a case-control study nested within the EPIC cohort

Author

Cairat, Manon, primary, Rinaldi, Sabina, additional, Navionis, Anne-Sophie, additional, Romieu, Isabelle, additional, Biessy, Carine, additional, Viallon, Vivian, additional, Olsen, Anja, additional, Tjønneland, Anne, additional, Fournier, Agnès, additional, Severi, Gianluca, additional, Kvaskoff, Marina, additional, Fortner, Renée T., additional, Kaaks, Rudolf, additional, Aleksandrova, Krasimira, additional, Schulze, Matthias B., additional, Masala, Giovanna, additional, Tumino, Rosario, additional, Sieri, Sabina, additional, Grasso, Chiara, additional, Mattiello, Amalia, additional, Gram, Inger T., additional, Olsen, Karina Standahl, additional, Agudo, Antonio, additional, Etxezarreta, Pilar Amiano, additional, Sánchez, Maria-Jose, additional, Santiuste, Carmen, additional, Barricarte, Aurelio, additional, Monninkhof, Evelyn, additional, Hiensch, Anouk E., additional, Muller, David, additional, Merritt, Melissa A., additional, Travis, Ruth C., additional, Weiderpass, Elisabete, additional, Gunter, Marc J., additional, and Dossus, Laure, additional

Published
2022
Full Text
View/download PDF

3. Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer

Author

Mukama, Trasias, primary, Fortner, Renée Turzanski, additional, Katzke, Verena, additional, Hynes, Lucas Cory, additional, Petrera, Agnese, additional, Hauck, Stefanie M., additional, Johnson, Theron, additional, Schulze, Matthias, additional, Schiborn, Catarina, additional, Rostgaard-Hansen, Agnetha Linn, additional, Tjønneland, Anne, additional, Overvad, Kim, additional, Pérez, María José Sánchez, additional, Crous-Bou, Marta, additional, Chirlaque, María-Dolores, additional, Amiano, Pilar, additional, Ardanaz, Eva, additional, Watts, Eleanor L., additional, Travis, Ruth C., additional, Sacerdote, Carlotta, additional, Grioni, Sara, additional, Masala, Giovanna, additional, Signoriello, Simona, additional, Tumino, Rosario, additional, Gram, Inger T., additional, Sandanger, Torkjel M., additional, Sartor, Hanna, additional, Lundin, Eva, additional, Idahl, Annika, additional, Heath, Alicia K., additional, Dossus, Laure, additional, Weiderpass, Elisabete, additional, and Kaaks, Rudolf, additional

Published
2022
Full Text
View/download PDF

4. Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study

Author

Castro-Espin, Carlota, primary, Agudo, Antonio, additional, Bonet, Catalina, additional, Katzke, Verena, additional, Turzanski-Fortner, Renée, additional, Aleksandrova, Krasimira, additional, Schulze, Matthias B., additional, Tjønneland, Anne, additional, Dahm, Christina C., additional, Quirós, José-Ramón, additional, Sánchez, María-José, additional, Amiano, Pilar, additional, Chirlaque, María-Dolores, additional, Ardanaz, Eva, additional, Masala, Giovanna, additional, Sieri, Sabina, additional, Tumino, Rosario, additional, Sacerdote, Carlotta, additional, Panico, Salvatore, additional, May, Anne M., additional, Bodén, Stina, additional, Gram, Inger T., additional, Skeie, Guri, additional, Laouali, Nasser, additional, Shah, Sanam, additional, Severi, Gianluca, additional, Aune, Dagfinn, additional, Merritt, Melissa A., additional, Cairat, Manon, additional, Weiderpass, Elisabete, additional, Riboli, Elio, additional, Dossus, Laure, additional, and Jakszyn, Paula, additional

Published
2021
Full Text
View/download PDF

5. Development and validation of circulating CA125 prediction models in postmenopausal women

Author

Sasamoto, Naoko, primary, Babic, Ana, additional, Rosner, Bernard A., additional, Fortner, Renée T., additional, Vitonis, Allison F., additional, Yamamoto, Hidemi, additional, Fichorova, Raina N., additional, Titus, Linda J., additional, Tjønneland, Anne, additional, Hansen, Louise, additional, Kvaskoff, Marina, additional, Fournier, Agnès, additional, Mancini, Francesca Romana, additional, Boeing, Heiner, additional, Trichopoulou, Antonia, additional, Peppa, Eleni, additional, Karakatsani, Anna, additional, Palli, Domenico, additional, Grioni, Sara, additional, Mattiello, Amalia, additional, Tumino, Rosario, additional, Fiano, Valentina, additional, Onland-Moret, N. Charlotte, additional, Weiderpass, Elisabete, additional, Gram, Inger T., additional, Quirós, J. Ramón, additional, Lujan-Barroso, Leila, additional, Sánchez, Maria-Jose, additional, Colorado-Yohar, Sandra, additional, Barricarte, Aurelio, additional, Amiano, Pilar, additional, Idahl, Annika, additional, Lundin, Eva, additional, Sartor, Hanna, additional, Khaw, Kay-Tee, additional, Key, Timothy J., additional, Muller, David, additional, Riboli, Elio, additional, Gunter, Marc, additional, Dossus, Laure, additional, Trabert, Britton, additional, Wentzensen, Nicolas, additional, Kaaks, Rudolf, additional, Cramer, Daniel W., additional, Tworoger, Shelley S., additional, and Terry, Kathryn L., additional

Published
2019
Full Text
View/download PDF

7. An epidemiological model for prediction of endometrial cancer risk in Europe

Author

Hüsing, Anika, primary, Dossus, Laure, additional, Ferrari, Pietro, additional, Tjønneland, Anne, additional, Hansen, Louise, additional, Fagherazzi, Guy, additional, Baglietto, Laura, additional, Schock, Helena, additional, Chang-Claude, Jenny, additional, Boeing, Heiner, additional, Steffen, Annika, additional, Trichopoulou, Antonia, additional, Bamia, Christina, additional, Katsoulis, Michalis, additional, Krogh, Vittorio, additional, Palli, Domenico, additional, Panico, Salvatore, additional, Onland-Moret, N. Charlotte, additional, Peeters, Petra H., additional, Bueno-de-Mesquita, H. Bas, additional, Weiderpass, Elisabete, additional, Gram, Inger T., additional, Ardanaz, Eva, additional, Obón-Santacana, Mireia, additional, Navarro, Carmen, additional, Sánchez-Cantalejo, Emilio, additional, Etxezarreta, Nerea, additional, Allen, Naomi E., additional, Khaw, Kay Tee, additional, Wareham, Nick, additional, Rinaldi, Sabina, additional, Romieu, Isabelle, additional, Merritt, Melissa A., additional, Gunter, Marc, additional, Riboli, Elio, additional, and Kaaks, Rudolf, additional

Published
2015
Full Text
View/download PDF

10. Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition

Author

Tsilidis, Konstantinos K., primary, Allen, Naomi E., additional, Key, Timothy J., additional, Dossus, Laure, additional, Kaaks, Rudolf, additional, Bakken, Kjersti, additional, Lund, Eiliv, additional, Fournier, Agnès, additional, Dahm, Christina C., additional, Overvad, Kim, additional, Hansen, Louise, additional, Tjønneland, Anne, additional, Rinaldi, Sabina, additional, Romieu, Isabelle, additional, Boutron-Ruault, Marie-Christine, additional, Clavel-Chapelon, Francoise, additional, Lukanova, Annekatrin, additional, Boeing, Heiner, additional, Schütze, Madlen, additional, Benetou, Vassiliki, additional, Palli, Domenico, additional, Berrino, Franco, additional, Galasso, Rocco, additional, Tumino, Rosario, additional, Sacerdote, Carlotta, additional, Bueno-de-Mesquita, H. Bas, additional, van Duijnhoven, Fränzel J. B., additional, Braem, Marieke G. M., additional, Onland-Moret, N. Charlotte, additional, Gram, Inger T., additional, Rodríguez, Laudina, additional, Duell, Eric J., additional, Sánchez, María-José, additional, Huerta, José María, additional, Ardanaz, Eva, additional, Amiano, Pilar, additional, Khaw, Kay-Tee, additional, Wareham, Nick, additional, and Riboli, Elio, additional

Published
2011
Full Text
View/download PDF

11. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density

Author

Biong, Margarethe, primary, Gram, Inger T, additional, Brill, Ilene, additional, Johansen, Fredrik, additional, Solvang, Hiroko K, additional, Alnaes, Grethe IG, additional, Fagerheim, Toril, additional, Bremnes, Yngve, additional, Chanock, Stephen J, additional, Burdett, Laurie, additional, Yeager, Meredith, additional, Ursin, Giske, additional, and Kristensen, Vessela N, additional

Published
2010
Full Text
View/download PDF

16. Development and validation of circulating CA125 prediction models in postmenopausal women

Author

Sasamoto, Naoko, Babic, Ana, Rosner, Bernard A, Fortner, Renée T, Vitonis, Allison F, Yamamoto, Hidemi, Fichorova, Raina N, Titus, Linda J, Tjønneland, Anne, Hansen, Louise, Kvaskoff, Marina, Fournier, Agnès, Mancini, Francesca Romana, Boeing, Heiner, Trichopoulou, Antonia, Peppa, Eleni, Karakatsani, Anna, Palli, Domenico, Grioni, Sara, Mattiello, Amalia, Tumino, Rosario, Fiano, Valentina, Onland-Moret, N Charlotte, Weiderpass, Elisabete, Gram, Inger T, Quirós, J Ramón, Lujan-Barroso, Leila, Sánchez, Maria-Jose, Colorado-Yohar, Sandra, Barricarte, Aurelio, Amiano, Pilar, Idahl, Annika, Lundin, Eva, Sartor, Hanna, Khaw, Kay-Tee, Key, Timothy J, Muller, David, Riboli, Elio, Gunter, Marc, Dossus, Laure, Trabert, Britton, Wentzensen, Nicolas, Kaaks, Rudolf, Cramer, Daniel W, Tworoger, Shelley S, and Terry, Kathryn L

Subjects
2. Zero hunger, endocrine system diseases, Early detection, Middle Aged, Models, Theoretical, female genital diseases and pregnancy complications, 3. Good health, Postmenopause, CA125, Ovarian cancer, Prediction model, CA-125 Antigen, Neoplasms, Humans, Postmenopausal, Female, Early Detection of Cancer, Aged
Abstract

BACKGROUND: Cancer Antigen 125 (CA125) is currently the best available ovarian cancer screening biomarker. However, CA125 has been limited by low sensitivity and specificity in part due to normal variation between individuals. Personal characteristics that influence CA125 could be used to improve its performance as screening biomarker. METHODS: We developed and validated linear and dichotomous (≥35 U/mL) circulating CA125 prediction models in postmenopausal women without ovarian cancer who participated in one of five large population-based studies: Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO, n = 26,981), European Prospective Investigation into Cancer and Nutrition (EPIC, n = 861), the Nurses' Health Studies (NHS/NHSII, n = 81), and the New England Case Control Study (NEC, n = 923). The prediction models were developed using stepwise regression in PLCO and validated in EPIC, NHS/NHSII and NEC. RESULT: The linear CA125 prediction model, which included age, race, body mass index (BMI), smoking status and duration, parity, hysterectomy, age at menopause, and duration of hormone therapy (HT), explained 5% of the total variance of CA125. The correlation between measured and predicted CA125 was comparable in PLCO testing dataset (r = 0.18) and external validation datasets (r = 0.14). The dichotomous CA125 prediction model included age, race, BMI, smoking status and duration, hysterectomy, time since menopause, and duration of HT with AUC of 0.64 in PLCO and 0.80 in validation dataset. CONCLUSIONS: The linear prediction model explained a small portion of the total variability of CA125, suggesting the need to identify novel predictors of CA125. The dichotomous prediction model showed moderate discriminatory performance which validated well in independent dataset. Our dichotomous model could be valuable in identifying healthy women who may have elevated CA125 levels, which may contribute to reducing false positive tests using CA125 as screening biomarker.

Catalog

Books, media, physical & digital resources
See catalog results